Literature DB >> 15933821

Brachytherapy for brain tumors.

Todd W Vitaz1, Peter C Warnke, Viviane Tabar, Philip H Gutin.   

Abstract

Over the past several decades neurooncologists have attempted to find an adjuvant treatment that prolongs survival for patients with malignant brain tumors. Brachytherapy, radiotherapy delivered by placing radioactive sources directly into the tumor, was initially thought to be the solution to this problem. Initial single institution studies showed very promising results; however, this technique has failed to show a significant survival advantage in two randomized studies. Despite this, brachytherapy continues to be used in a number of centers throughout the world for the treatment of various types of brain tumors including low-grade gliomas, anaplastic astrocytomas, glioblastomas, meningiomas and metastases. This article reviews brachytherapy's rationale, radiobiology, complications, indications, and results from numerous studies that have focused on its application for brain tumors with emphasis on its application for glial tumors.

Entities:  

Mesh:

Year:  2005        PMID: 15933821     DOI: 10.1007/s11060-004-2352-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  162 in total

1.  Interstitial brachytherapy for metastatic brain tumors.

Authors:  M Prados; S Leibel; C M Barnett; P Gutin
Journal:  Cancer       Date:  1989-02-15       Impact factor: 6.860

2.  Dose tables for 125I seed implants.

Authors:  V Krishnaswamy
Journal:  Radiology       Date:  1979-09       Impact factor: 11.105

3.  Comparison between tumor pH and cell sensitivity to heat in RIF-1 tumors.

Authors:  M Hiraoka; G M Hahn
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

4.  Interstitial thermoradiotherapy of brain tumors: preliminary results of a phase I clinical trial.

Authors:  B Stea; T C Cetas; J R Cassady; A N Guthkelch; R Iacono; B Lulu; W Lutz; E Obbens; K Rossman; J Seeger
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-12       Impact factor: 7.038

5.  Interstitial irradiation of cerebral gliomas with stereotactically implanted iodine-125 seeds.

Authors:  J Voges; H Treuer; W Schlegel; O Pastyr; V Sturm
Journal:  Acta Neurochir Suppl (Wien)       Date:  1993

6.  Interstitial iodine-125 radiosurgery for cerebral metastases.

Authors:  C B Ostertag; F W Kreth
Journal:  Br J Neurosurg       Date:  1995       Impact factor: 1.596

7.  Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.

Authors:  D F Nelson; M Diener-West; J Horton; C H Chang; D Schoenfeld; J S Nelson
Journal:  NCI Monogr       Date:  1988

8.  Interstitial 125-iodine radiosurgery of low-grade gliomas of the insula of Reil.

Authors:  C R Schätz; F W Kreth; M Faist; P C Warnke; B Volk; C B Ostertag
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Computer-assisted CT-guided stereotactic biopsy and brachytherapy of brain tumors.

Authors:  R Quiñones-Molina; A Alaminos; H Molina; J Muñoz; G López; L Alvarez; I Ortega; J Piedra; W Soler; A Torres
Journal:  Stereotact Funct Neurosurg       Date:  1994       Impact factor: 1.875

10.  Cerebral necrosis following irradiation and chemotherapy for metastatic choriocarcinoma.

Authors:  R A Pratt; G Di Chiro; J C Weed
Journal:  Surg Neurol       Date:  1977-03
View more
  12 in total

1.  Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases.

Authors:  Philipp Kickingereder; Christina Hamisch; Bogdana Suchorska; Norbert Galldiks; Veerle Visser-Vandewalle; Roland Goldbrunner; Martin Kocher; Harald Treuer; Juergen Voges; Maximilian I Ruge
Journal:  J Neurooncol       Date:  2014-08-24       Impact factor: 4.130

2.  Intracavitary moderator balloon combined with (252)Cf brachytherapy and boron neutron capture therapy, improving dosimetry in brain tumour and infiltrations.

Authors:  S F Brandão; T P R Campos
Journal:  Br J Radiol       Date:  2015-04-30       Impact factor: 3.039

Review 3.  Brachytherapy for central nervous system tumors.

Authors:  Evan D Bander; Jonathan P S Knisely; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2022-05-11       Impact factor: 4.130

Review 4.  Controversies concerning the application of brachytherapy in central nervous system tumors.

Authors:  Bo-Lin Liu; Jin-Xiang Cheng; Xiang Zhang; Wei Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02       Impact factor: 4.553

5.  Translation of the ecological trap concept to glioma therapy: the cancer cell trap concept.

Authors:  Boudewijn van der Sanden; Florence Appaix; François Berger; Laurent Selek; Jean-Paul Issartel; Didier Wion
Journal:  Future Oncol       Date:  2013-06       Impact factor: 3.404

6.  Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.

Authors:  Hussam Abou Al-Shaar; Kaith K Almefty; Mohammad Abolfotoh; Nils D Arvold; Phillip M Devlin; David A Reardon; Jay S Loeffler; Ossama Al-Mefty
Journal:  J Neurooncol       Date:  2015-08-08       Impact factor: 4.130

Review 7.  Use of antibodies and immunoconjugates for the therapy of more accessible cancers.

Authors:  Robert M Sharkey; David M Goldenberg
Journal:  Adv Drug Deliv Rev       Date:  2008-04-24       Impact factor: 15.470

Review 8.  Iodine-125 brachytherapy for brain tumours--a review.

Authors:  Silke B Schwarz; Niklas Thon; Katharina Nikolajek; Maximilian Niyazi; Joerg-Christian Tonn; Claus Belka; Friedrich-Wilhelm Kreth
Journal:  Radiat Oncol       Date:  2012-03-06       Impact factor: 3.481

9.  Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice.

Authors:  Joost J C Verhoeff; Lukas J A Stalpers; Annet W Coumou; Kees Koedooder; Cristina Lavini; Cornelis J F Van Noorden; Jaap Haveman; William P Vandertop; Wouter R van Furth
Journal:  Radiat Oncol       Date:  2007-09-26       Impact factor: 3.481

Review 10.  The Current and Future Treatment of Brain Metastases.

Authors:  Douglas A Hardesty; Peter Nakaji
Journal:  Front Surg       Date:  2016-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.